PHOENIX — Governor Doug Ducey today signed legislation to ensure patients and their doctors have access to innovative testing that can help determine the most effective medical treatment for cancer and other diseases.

Before signing the bill at the Dignity Health Cancer Institute at St. Joseph’s Hospital and Medical Center in Phoenix, the governor said Arizona now joins only a handful of other states in requiring health insurance plans to cover biomarker testing when there’s a clinical need.

“These types of tests have become a crucial part of cancer and other disease therapies and should be available to everyone who wants one,” said Governor Ducey. “Biomarker tests save lives. They help doctors determine the best course of treatment, prevent unnecessary treatments and will help us cure diseases like cancer in the future. No one should be denied this information.”

The legislation, H.B. 2144, was sponsored by Rep. Regina Cobb of Kingman and passed with strong bipartisan support in the Arizona House and Senate. Continue reading→

Professional Employer Orgs (PEOs) can support your business and help take the headaches out of your company’s HR experience.  Learn more about this program from AZBio and BIO Business Solutions®.Continue reading→

20 years ago, TGen, the Translational Genomics Research Institute was a vision our community embraced. Today, TGen is an Arizona-based, nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results. TGen works to unravel the genetic components of common and complex diseases, including cancer, neurological disorders, infectious disease, and rare childhood disorders. By identifying treatment options in this manner, TGen believes medicine becomes more rational, more precise and, well, more personal.Continue reading→

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Franklin Mountain Medical announced today that the company has received FDA clearance of its patented UltraNav Transseptal Catheter System for controlled access and delivery of cardiovascular catheters and guidewires to the heart chambers via transseptal puncture.Continue reading→

Researchers at the Center for Innovation in Brain Science received a $7.6 million grant to investigate PhytoSERM, a dietary supplement that may be able to treat menopausal symptoms and lower the risk of Alzheimer’s disease.Continue reading→

New $45M liquid biopsy lab and diagnostic testing facility creates hundreds of new bioscience job opportunities in PhoenixContinue reading→

Institute will drive sustainable innovation in three areas of environmental stewardship, furthering progress toward the company’s 2030+ environmental, social and governance (ESG) commitmentsContinue reading→

In partnership with Arizona BioIndustry Association (AZBio), Booth Udall Fuller and Perkins Coie are offering weekly office hours to give AZBio members the opportunity to ask questions regarding the legal strategies of their businesses.

Continue reading→

The April 20 report, the latest performance analysis commissioned by the Phoenix-based Flinn Foundation and presented by TEConomy Partners, shows record highs in bioscience jobs, wages, venture capital, National Institutes of Health research funding, and university research and development.Continue reading→

TUCSON, AZ / ACCESSWIRE / April 20, 2022 / Aqualung Therapeutics, an early stage immunotherapeutics biotech company developing an anti-inflammatory therapeutic platform for serious unchecked inflammatory disorders, announced the signing of a license agreement with the LeaderMed Health Group Limited (“LeaderMed”). The License Agreement provides LeaderMed with Asia-Pacific regional rights to further develop, manufacture, and commercialize the eNAMPT-neutralizing mAb, ALT-100 platform technology. The terms of the agreement have not been publicly disclosed but involve customary upfront fees, achievement milestones, and royalties that coincide with commercial sales.Continue reading→